PDGF-BB alleviates pericyte damage by the activation of the PHF19-PRC2 complex via the miR-221/BRCA1 axis in Alzheimer's disease

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background PDGF-BB is one of the important factors to maintain the function of pericytes. Pericyte damage accelerates the progression of Alzheimer's disease (AD). The role of PDGF-BB in AD was verified in this study. Methods Pericytes were treated with Aβ1-42 or combined with PDGF-BB. CCK-8 assay, EdU assay and flow cytometry examined cell viability, proliferation and apoptosis. Co-Immunoprecipitation verified the relationship among BRCA1, PHF19, EZH2, EED, SUZ12 and RbAp46/48.Luciferase reporter assay verified the relationship among BRCA1, miR-221-3p and miR-222-3p. APP/PS1 mice were administrated with PDGF-BB. Morris water maze test examined animal behaviors.Immunofluorescence staining and Evans Blue assay examined the pericyte coverage and blood brain barrier (BBB) integrity. Results PDGF-BB enhanced cell viability and proliferation, while inhibited apoptosis of Aβ1-42-treated pericytes, which was abrogated by BRCA1 overexpression. BRCA1 was up-regulated in Aβ1-42-treated pericytes. Additionally, PDGF-BB treatment caused a down-regulation of BRCA1 and up-regulation of PHF19-PRC2 complex members, PHF19, EZH2, EED, SUZ12 and RbAp46/48. BRCA1 interacted with PHF19-PRC2 complex members. MiR-221 repressed BRCA1 expression by targeting BRCA1. MiR-222 interacted with BRCA1 and had no influence on BRCA1 expression. In vivo , PDGF-BB treatment ameliorated learning and memory ability and elevated pericyte coverage and BBB integrity in AD mice. Conclusion PDGF-BB activated PHF19-PRC2 complex by regulating miR-221/BRCA1 axis, thereby reducing the permeability of BBB and ameliorating the learning and memory ability of AD mice. Thus, PDGF-BB may play a therapeutic role in AD development.

Article activity feed